This was verified by the findings that downregulated CXCL2 reduced the infiltration of MDSCs and tumor growth, while early-life microbiota restricted MDSC-driven carcinogenesis by dampening the production of CXCL2 [98,99]. The gene discussed is CXCL2; the disease is neoplasm.